Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | GFPT1 | Q06210 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SYK | P43405 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 4/20 | 0.41 |
| ▸ | CTSK | P43235 | 4/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CASR | P41180 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL997508 | 1.00 | MEN1 (0.53) | MEN1GAAKMT2AGFPT1TDP1 | |
| SCHEMBL994583 | 1.00 | MEN1 (0.53) | MEN1GAAKMT2AGFPT1TDP1 | |
| Hydrochloric Acid SCHEMBL2680968 | 0.98 | MEN1 (0.51) | MEN1GAAKMT2AGFPT1TDP1 | |
| Hydrochloric Acid SCHEMBL668972 | 0.98 | MEN1 (0.51) | MEN1GAAKMT2AGFPT1TDP1 | |
| Hydrochloric Acid SCHEMBL2681229 | 0.98 | MEN1 (0.51) | MEN1GAAKMT2AGFPT1TDP1 | |
| Chloromethane SCHEMBL17911911 | 0.98 | MEN1 (0.51) | MEN1GAAKMT2AGFPT1TDP1 | |
| Formic Acid SCHEMBL7370577 | 0.93 | MEN1 (0.47) | MEN1GAAKMT2AGFPT1TDP1 | |
| SCHEMBL23455458 | 0.89 | MEN1 (0.46) | MEN1GAAKMT2AGFPT1TDP1 | |
| SCHEMBL23455605 | 0.89 | MEN1 (0.46) | MEN1GAAKMT2AGFPT1TDP1 | |
| SCHEMBL13365413 | 0.86 | MEN1 (0.47) | MEN1GAAKMT2AGFPT1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112125819-B | Preparation method of dencichine | 兰州百源基因技术有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-112125819-A | Preparation method of sanchinin | 兰州百源基因技术有限公司 | 2020-12-25 | — | — | CN | claimed |
| CN-109748813-A | A kind of synthetic method improvement of dencichine | 西安格硕信息科技有限公司 | 2019-05-14 | — | — | CN | claimed |
| CN-105061247-A | Improved synthesis method for dencichine | XI AN YUEDA PLANT SCIENCE AND TECHNOLOGY CO LTD | 2015-11-18 | — | — | CN | claimed |
| EP-1506970-A1 | COMPOUNDS WHICH CAN BLOCK THE RESPONSE TO CHEMICAL SUBSTANCES OR THERMAL STIMULI OR MEDIATORS OF INFLAMMATION OF NOCICEPTORS, PRODUCTION METHOD THEREOF AND COMPOSITIONS CONTAINING SAME | Diverdrugs, S.L. (ES) | 2005-02-16 | — | — | EP | claimed |
| EP-4719381-A1 | LIGAND-POLAR DRUG CONJUGATES | Tripartite Therapeutics Inc. (TW) | 2026-04-08 | — | — | EP | disclosed |
| EP-3681875-B1 | CYCLIC PEPTIDE ANTIBIOTICS | HOFFMANN LA ROCHE (CH) | 2026-01-14 | — | — | EP | disclosed |
| CN-111148739-B | Cyclic peptide antibiotics | 豪夫迈·罗氏有限公司 | 2025-06-03 | — | — | CN | disclosed |
| EP-4548937-A1 | ANTIBODY-DRUG COMPLEX | Eisai R&D Management Co., Ltd. (JP) | 2025-05-07 | — | — | EP | disclosed |
| US-20250129125-A1 | MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2025-04-24 | — | — | US | disclosed |
| US-12195796-B2 | Cyclooctatetraene containing dyes and compositions | ILLUMINA CAMBRIDGE LIMITED (GB) | 2025-01-14 | — | — | US | disclosed |
| US-20250009915-A1 | NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF | FUJIFILM CORPORATION (JP) | 2025-01-09 | — | — | US | disclosed |
| US-6204282-B1 | TREATING CANCER, RETINOPATHY, ATHEROSCLEROSIS, VASCULAR RESTENOSIS, OR OSTEOPOROSIS. | SCHERING CORPORATION | 2001-03-20 | — | — | US | disclosed |
| WO-2000032578-A1 | BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS | SCHERING CORPORATION (US) | 2000-06-08 | — | — | WO | disclosed |
| EP-0970950-A2 | Novel isoxazoline and isoxazole fibrinogen receptor antagonists | DuPont Pharmaceuticals Company (US) | 2000-01-12 | — | — | EP | disclosed |
| EP-0832076-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-04-01 | — | — | EP | disclosed |
| CN-1138322-A | 2,3-diaminopropionic acid derivative | SUMITOMO PHARMA (JP) | 1996-12-18 | — | — | CN | disclosed |
| EP-0664711-A1 | PEPTIDE INHIBITORS OF CELLULAR ADHESION | CENTOCOR INC. (US) | 1995-08-02 | — | — | EP | disclosed |
| WO-1994005310-A1 | PEPTIDE INHIBITORS OF CELLULAR ADHESION | CENTOCOR, INC. (US) | 1994-03-17 | — | — | WO | disclosed |
| EP-0350163-A2 | Renin inhibitory peptides | BEECHAM GROUP PLC (GB) | 1990-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129125-A1 | MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | PAICS, CYCS, LSS | MEN1 495/4885GAA 1370/4885KMT2A 2834/4885 |
| US-20250009915-A1 | NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF | SLC39A3, SLC39A14, SLC39A11 | MEN1 45/4885GAA 4491/4885KMT2A 1691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.